Monoclonal antibodies specific to porin of Haemophilus influenzae type b: localization of their cognate epitopes and tests of their biological activities. 1992

R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada.

The major outer membrane protein of Haemophilus influenzae type b (Hib) is porin (Mr 38,000, 341 amino acids). To identify antigenic determinants on Hib porin that might be exposed at the bacterial cell surface, seven mouse monoclonal anti-Hib porin antibodies were generated. The monoclonal antibodies were tested for their binding to intact cells by flow cytometry; all but one bound to the cell surface. Digestions of Hib porin with cyanogen bromide, hydroxylamine or trypsin generated fragments, the identities of which were confirmed by microsequencing of the amino termini. Following electrophoresis and immunoblotting of the fragments, the specificities of the monoclonal antibodies for their cognate sequences were determined. The porin gene ompP2 was expressed in the baculovirus expression vector system; the recombinant porin was recognized by all of the monoclonal antibodies. Deletions were created by omega mutagenesis of ompP2, generating proteins truncated after amino acids 139, 174, 182, and 264. These deletion proteins were tested for reactivities with the monoclonal antibodies, thereby establishing the boundaries of three antigenic determinants that were recognized by the monoclonals: domain (i), amino acids 104-139; domain (ii) amino acids 162-174; and domain (iii), amino acids 267-341. The biological activities of monoclonal antibodies that were representative of these three classes were tested for their bactericidal activity in complement-mediated lysis of whole cells. The monoclonal antibodies were also tested for their immunoprotective properties in the infant rat model of bacteraemia. Although the monoclonal antibodies were surface-binding, they were neither bactericidal nor protective.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
May 1993, Infection and immunity,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
June 1992, The Journal of infectious diseases,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
August 1990, Microbial pathogenesis,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
April 1988, European journal of immunology,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
June 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
January 1992, Journal of general microbiology,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
November 1974, The Journal of infectious diseases,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
April 1991, Infection and immunity,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
May 1991, Pediatric research,
R Srikumar, and A C Chin, and V Vachon, and C D Richardson, and M J Ratcliffe, and L Saarinen, and H Käyhty, and P H Mäkelä, and J W Coulton
July 1990, Infection and immunity,
Copied contents to your clipboard!